Pages that link to "Q28067056"
Jump to navigation
Jump to search
The following pages link to Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases (Q28067056):
Displaying 12 items.
- Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds (Q38656262) (← links)
- Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade. (Q42372881) (← links)
- Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores. (Q47416768) (← links)
- Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior. (Q51007789) (← links)
- Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats. (Q53103700) (← links)
- Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening (Q57712447) (← links)
- [--C]-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1-indole-2-carboxamide ([C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey (Q58576516) (← links)
- Inclusion of enclosed hydration effects in the binding free energy estimation of dopamine D3 receptor complexes (Q90375092) (← links)
- Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens (Q92414811) (← links)
- The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans (Q93162732) (← links)
- Self-Assembly and Biorecognition of a Spirohydantoin Derived from α-Tetralone: Interplay between Chirality and Intermolecular Interactions (Q96220263) (← links)
- Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Q97066895) (← links)